This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toledo, E., Inestrosa, N. Wnt signaling activation reduces neuropathological markers in a mouse model of Alzheimer's disease. Mol Psychiatry 15, 228 (2010). https://doi.org/10.1038/mp.2010.9
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2010.9
This article is cited by
-
Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus
Scientific Reports (2019)
-
Resveratrol Protects SAMP8 Brain Under Metabolic Stress: Focus on Mitochondrial Function and Wnt Pathway
Molecular Neurobiology (2017)
-
Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer’s Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway
Neurotoxicity Research (2016)
-
Combination of PPT with LiCl Treatment Prevented Bilateral Ovariectomy-Induced Hippocampal-Dependent Cognition Deficit in Rats
Molecular Neurobiology (2016)
-
Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice
Molecular Neurodegeneration (2014)